secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-PATH HOLDINGS, INC. (BPTH)
CIK:        0001133818
Form:       8-K
Filed at:   2025-10-29T23:59:59+00:00
Accession:  0001663577-25-000303
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Path appoints Vikram Grover as CEO, CFO and director; Morris resigns as interim CEO/CFO
--------------------------------------------------------------------------------

- Vikram Grover elected President, CEO, CFO and Board member effective October 22, 2025.
- Douglas Morris resigned as Interim CEO and Interim CFO but remains on the Board.
- Paul Aubert resigned as director, effective October 22, 2025.
- Grover now holds both CEO and CFO roles, consolidating leadership.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133818/000166357725000303/0001663577-25-000303-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133818/000166357725000303/bpth_8k102225.htm
  HTML page:      https://secwatch.observer/filing/0001663577-25-000303

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer